COMMUNIQUÉS West-GlobeNewswire

Benitec Biopharma Releases Full Year 2025 Financial Results and Provides Operational Update
22/09/2025
Interim Clinical Study Results for Cohort 1 of the BB-301 Phase 1b/2a Treatment Study Anticipated in Q4 2025 Enrollment of the First Subject into Cohort 2 of the BB-301 Phase 1b/2a Treatment Study Expected in Q4 2025 [...]
J-Star Holding Names Sam Van as Chief Executive Officer
22/09/2025
TAICHUNG CITY, Taiwan, Sept. 22, 2025 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), a leading provider of innovative carbon fiber and composite solutions across a wide range of [...]
ArriVent Appoints Brent S. Rice as Chief Commercial Officer
22/09/2025
NEWTOWN SQUARE, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative [...]
Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform
22/09/2025
AI-Powered Heartflow Plaque Analysis to be Covered by Cigna Health Plans Nationwide MOUNTAIN VIEW, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for [...]
Eupraxia Pharmaceuticals Announces Proposed Public Offering of Common Shares
22/09/2025
VICTORIA, British Columbia, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary [...]
Until Labs Announces $58M Series A Funding Round, to Develop an Organ Cryopreservation Product for Transplant Patients and Surgeons
22/09/2025
This investment, led by Founders Fund with participation from Lux Capital and Field Ventures, brings total investment to date to $100M+, and will be used to build out the team and operational infrastructure SAN [...]
Lexicon Pharmaceuticals Announces Update on Submission of Additional Data to U.S. FDA Supporting the Benefit-Risk Profile of Zynquista® in Type 1 Diabetes
22/09/2025
Data obtained from ongoing third-party funded, investigator-sponsored trials have been submitted in effort to address the December 2024 complete response letter Company seeks alignment on reasonable path forward for [...]
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce the Closing of Their Previously Announced Business Combination
22/09/2025
Semnur’s shares of common stock and warrants are expected to continue to trade on the OTC Markets under the ticker symbols “SMNR” and “SMNRW”, respectively. Scilex (together with its affiliates) owns approximately 87.5 [...]
The Sentinel Introduces Transformative Approach to Healing in British Columbia, Setting a New Standard in Integrative Care
22/09/2025
KASLO, BC, Sept. 22, 2025 (GLOBE NEWSWIRE) -- The Sentinel , a leading wellness centre, today announced a major initiative advancing the integration of traditional healing practices with contemporary therapeutic [...]
MEDIA ADVISORY - Protests Against Ford Government’s Expanding Hospital Privatization Plans
22/09/2025
TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- “The Ford government is privatizing our public hospitals in a move that is costing patients thousands of dollars and taking away from our local public hospital services. [...]

Pages